Objective–To investigate the effect of treatment with the glucagon-like peptide 1 receptor agonist exenatide on weight loss and metabolic parameters in obese nondiabetic women. Research Design ...
Objective Exenatide improves postprandial glycemic excursions in type 2 diabetes. Exenatide could benefit type 1 diabetes as well. We aimed to determine an effective and safe glucose-lowering ...
Hosted on MSN1mon
Diabetes drug similar to Ozempic showed no benefits for patients with Parkinson’s diseaseHalf of the participants received a weekly injection of two milligrams of the drug exenatide, which is a GLP-1 receptor agonist similar to medicines such as Ozempic or Wegovy. The other half of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback